July 01, 2026 article Open access Österreichischer Lipidkonsensus 2026 Wiener klinische Wochenschrift DOI: 10.1007/s00508-026-02760-6 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 7 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk 2022 New England Journal of Medicine article Medicine Lipoproteins and Cardiovascular Health Open access cited by 2 patents 751 citations Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access cited by 1 patent 604 citations Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome 2020 Circulation article Medicine Lipoproteins and Cardiovascular Health Open access 193 citations Familial Hypercholesterolemia 2021 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access 91 citations Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry 2025 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access 60 citations Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation 2024 European Heart Journal - Cardiovascular Pharmacotherapy article Medicine Lipoproteins and Cardiovascular Health Open access 25 citations Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial 2026 European Heart Journal article Medicine Lipoproteins and Cardiovascular Health Open access 8 citations 7 results